Acute anticonvulsant effects of dapsone on PTZ- and MES-induced seizures in mice: NLRP3 inflammasome inhibition and Nrf2/HO-1 pathway preservation
- 27 January 2025
- journal article
- research article
- Published by Springer Nature in Pharmacological Reports
- Vol. 77 (2) , 450-462
Abstract
Background Epilepsy, a neurological disorder characterized by recurrent seizures, presents considerable difficulties in treatment, particularly when dealing with drug-resistant cases. Dapsone, recognized for its anti-inflammatory properties, holds promise as a potential therapeutic option. However, its effectiveness in epilepsy requires further investigation. The aim of this study is to explore the effects of dapsone on seizure activity and neuroinflammation, particularly through the nuclear factor erythroid-2-related factor (Nrf2)/ Heme Oxygenase 1 (HO-1) and NOD-like receptor family pyrin domain-containing 3 (NLRP3) pathways, to better understand its therapeutic potential. Methods To evaluate the effects of dapsone, two seizure models were utilized in mice: pentylenetetrazole (PTZ)-induced clonic seizures and maximal electroshock (MES)-induced generalized tonic-clonic seizures (GTCS) in mice. The impact of dapsone on neuroinflammatory markers and oxidative stress pathways, specifically Nrf2/HO-1 and NLRP3, as well as interleukin-1β (IL-1β), IL-8, and IL-18, was assessed using Western blotting and ELISA techniques. Results In this study, dapsone (2, 5, 10, and 20 mg/kg, ip) showcased a significant increase in clonic seizure threshold following intravenous infusion of PTZ. Notably, doses of 5, 10, and 20 mg/kg exhibited increased latency and decreased the number of seizures. Additionally, dapsone at 10 and 20 mg/kg prevented the incidence of GTCS and subsequent mortality in the MES model. Furthermore, Dapsone demonstrated modulation of Nrf2/ HO-1 and NLRP3 IL-1 β/IL-18 pathways. Conclusion This study highlights the therapeutic potential of dapsone in epilepsy, emphasizing the involvement of Nrf2/HO-1 and NLRP3 pathways. These findings provide a foundation for future clinical research aimed at developing dapsone-based therapies for drug-resistant epilepsy.Keywords
Funding Information
- Tehran University of Medical Sciences and Health Services (1403-1-101-71066)
This publication has 65 references indexed in Scilit:
- Conditional Knockout of IL-1R1 in Endothelial Cells Attenuates Seizures and Neurodegeneration via Inhibiting Neuroinflammation Mediated by Nrf2/HO-1/NLRP3 Signaling in Status Epilepticus ModelMolecular Neurobiology, 2023
- Ginger (Zingiber Officinale Roscoe) ameliorates ethanol-induced cognitive impairment by modulating NMDA and GABA-A receptors in rat hippocampusMetabolic Brain Disease, 2023
- Modulating Nrf-2/HO-1, apoptosis and oxidative stress signaling pathways by gabapentin ameliorates sepsis-induced acute kidney injuryNaunyn-Schmiedeberg's Archives of Pharmacology, 2023
- Possible Interaction of Opioidergic and Nitrergic Pathways in the Anticonvulsant Effect of Ivermectin on Pentylenetetrazole-Induced Clonic Seizures in MiceNeurochemical Research, 2022
- Proanthocyanidins alleviate pentylenetetrazole-induced epileptic seizures in mice via the antioxidant activityNeurochemical Research, 2022
- Increased circulation mobilization of endothelial progenitor cells in preterm infants with retinopathy of prematurityJournal of Cellular Biochemistry, 2018
- Far-infrared ray for treating chronic lower extremity lymphedema with dermatolymphangioadenitis: a postoperative complication of gynecological tumor resectionArchives of Gynecology and Obstetrics, 2017
- ECM‐Dependence of Endothelial Progenitor Cell FeaturesJournal of Cellular Biochemistry, 2016
- Dapsone in dermatology and beyondArchives of Dermatological Research, 2013
- Safety and tolerability of dapsone for the treatment of patients with drug-resistant, partial-onset seizures: an open-label trialNeurological Sciences, 2011